Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jun 1;90(11):4942-6.
doi: 10.1073/pnas.90.11.4942.

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

Affiliations

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

M Kovacsovics-Bankowski et al. Proc Natl Acad Sci U S A. .

Abstract

Antigens in extracellular fluids can be processed and presented with major histocompatibility complex (MHC) class I molecules by a subset of antigen presenting cells (APCs). Chicken egg ovalbumin (Ova) linked to beads was presented with MHC class I molecules by these cells up to 10(4)-fold more efficiently than soluble Ova. This enhanced presentation was observed with covalently or noncovalently linked Ova and with beads of different compositions. A key parameter in the activity of these conjugates was the size of the beads. The APC that is responsible for this form of presentation is a macrophage. These cells internalize the antigen constructs through phagocytosis, since cytochalasin B inhibited presentation. Processing of the antigen and association with MHC class I molecules appears to occur intracellularly as presentation was observed under conditions where there was no detectable release of peptides into the extracellular fluids. When injected in vivo in C57BL/6 mice, Ova-beads, but not soluble Ova, primed CD4- CD8+ cytotoxic T lymphocytes (CTLs). Similar results were obtained in BALB/c mice immunized with beta-galactosidase-beads. The implications of these findings for development of nonliving vaccines that stimulate CTL immunity are discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1976 May 1;143(5):1283-8 - PubMed
    1. J Immunol. 1993 Feb 15;150(4):1244-52 - PubMed
    1. J Immunol. 1981 Mar;126(3):1114-9 - PubMed
    1. J Immunol. 1981 May;126(5):1655-60 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4535-9 - PubMed

Publication types

MeSH terms